皮下ドラッグデリバリー機器市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

皮下ドラッグデリバリー機器市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の皮下ドラッグデリバリー機器市場規模は2030年までに518億米ドルに達し、2025～2030年にかけてCAGR 7.6％で成長すると予測されています。

慢性疾患の有病率の増加と、病気の症状を和らげるための定期的な薬剤投与が、家庭内薬剤投与装置の需要を高めています。米国疾病予防管理センター（CDC）によると、2018年、米国では約5,440万人（22.7％）の成人が関節炎、線維筋痛症、痛風、またはループスに苦しんでいます。

さらに、大量の投与や投与期間の延長を必要とする患者の生命を脅かす疾患の治療に対する生物製剤の承認件数が増加しており、皮下ドラッグデリバリー機器の需要を加速させています。英国Informaが2019年2月に発表した調査によると、臨床検査パイプラインにある医薬品の総数は、非経口投与が2018年の53.0%から2019年の55.0%に増加し、経口薬の製剤は2018年の33.0%から2019年の31.0%に全体的に減少しました。

皮下ドラッグデリバリー機器市場レポートハイライト

• 高齢者における慢性疾患の有病率の上昇と高い可処分所得により、北米が2024年に最大の売上シェアを占めました。
• 製品別では、複数回投与が容易で価格も手頃なペン型注射器が予測期間中に最も高いCAGRを記録する見込み。
• 流通チャネル別では、大規模な薬局チェーンが含まれ、新しいドラッグデリバリー機器に対する魅力的なスキームや割引があることから、小売薬局セグメントが最大の市場シェアを占めています。
• 市場参入企業は、世界市場における患者需要の増加に対応するため、戦略的提携や製品革新など、いくつかの戦略を採用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 皮下ドラッグデリバリー機器市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 皮下ドラッグデリバリー機器市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 皮下ドラッグデリバリー機器市場：製品別、推定・動向分析

• セグメントダッシュボード
• 皮下ドラッグデリバリー機器市場：製品変動分析
• 皮下ドラッグデリバリー機器市場：製品別展望
• 2018～2030年の市場規模と予測と動向分析
• プレフィルドシリンジ
• ペン型注射器
• オートインジェクター
• ウェアラブルインジェクター
• 無針注射器

第5章 皮下ドラッグデリバリー機器市場：流通チャネル別、推定・動向分析

• セグメントダッシュボード
• 皮下ドラッグデリバリー機器市場：流通チャネル変動分析
• 皮下ドラッグデリバリー機器市場：流通チャネル別展望
• 2018～2030年の市場規模と予測と動向分析
• 病院薬局
• 小売薬局
• オンライン薬局

第6章 皮下ドラッグデリバリー機器市場：地域別、推定・動向分析

• 地域ダッシュボード
• 皮下ドラッグデリバリー機器市場：地域別変動分析
• 皮下ドラッグデリバリー機器市場：流通チャネルと最終用途別の地域推定・動向分析
• 2018～2030年の市場規模と予測と動向分析
• 北米
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Gerresheimer AG
  • Medtronic Plc
  • Ypsomed AG
  • Elcam Medical Group
  • Novo Nordisk
  • Insulet Corporation
  • Becton, Dickinson and Company
  • West Pharmaceutical Services, Inc.
  • PharmaJet
  • Unilife Corporation
  • Inolife Sciences

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 4. Global subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 5. North America subcutaneous drug delivery devices market, by region, 2018 - 2030 (USD Million)
• Table 6. North America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 7. North America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 8. U.S. subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 9. U.S. subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 10. Canada subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 11. Canada subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12. Mexico subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 13. Mexico subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14. Europe subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
• Table 15. Europe subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 16. Europe subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 17. UK subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 18. UK subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19. Germany subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 20. Germany subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 21. France subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 22. France subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 23. Italy subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 24. Italy subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25. Spain subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 26. Spain subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27. Norway subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 28. Norway subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 29. Sweden subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 30. Sweden subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31. Denmark subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 32. Denmark subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 33. Asia Pacific subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
• Table 34. Asia Pacific subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 35. Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 36. Japan subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 37. Japan subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 38. China subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 39. China subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40. India subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 41. India subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42. Australia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 43. Australia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 44. South Korea subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 45. South Korea subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46. Thailand subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 47. Thailand subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 48. Latin America subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
• Table 49. Latin America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 50. Latin America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 51. Brazil subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 52. Brazil subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 53. Argentina subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 54. Argentina subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55. Middle East & Africa subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
• Table 56. Middle East & Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 57. Middle East & Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58. South Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 59. South Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60. Saudi Arabia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 61. Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 62. UAE subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 63. UAE subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64. Kuwait subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 65. Kuwait subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1. Information Procurement
• Fig. 2. Primary Research Pattern
• Fig. 3. Market Research Approaches
• Fig. 4. Value Chain-Based Sizing & Forecasting
• Fig. 5. Market Formulation & Validation
• Fig. 6. Subcutaneous drug delivery devices market segmentation
• Fig. 7. Market driver analysis (Current & future impact)
• Fig. 8. Market restraint analysis (Current & future impact)
• Fig. 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10. Porter's Five Forces Analysis
• Fig. 11. Subcutaneous drug delivery devices market, product outlook key takeaways (USD Million)
• Fig. 12. Subcutaneous drug delivery devices market product movement analysis (USD Million), 2024 & 2030
• Fig. 13. Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14. Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15. Auto injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16. Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17. Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18. Subcutaneous drug delivery devices market, distribution channel outlook key takeaways (USD Million)
• Fig. 19. Subcutaneous drug delivery devices market, distribution channel movement analysis (USD Million), 2024 & 2030
• Fig. 20. Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21. Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22. Online pharmacies market, application outlook key takeaways (USD Million)
• Fig. 23. Subcutaneous drug delivery devices market: Regional key takeaways (USD Million)
• Fig. 24. Subcutaneous drug delivery devices market regional outlook, 2024 & 2030, USD Million
• Fig. 25. North America subcutaneous drug delivery devices estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26. U.S. subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27. Canada subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28. Mexico subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29. Europe subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30. UK subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31. Germany subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32. France subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33. Spain subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34. Italy subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35. Sweden subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36. Norway subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37. Denmark subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38. Asia Pacific subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39. China subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40. Japan subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41. India subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42. South Korea subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43. Australia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44. Thailand subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45. Latin America subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46. Brazil subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47. Argentina subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48. Middle East and Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49. South Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50. Saudi Arabia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51. UAE subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52. Kuwait subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53. List of key emerging company's/distribution channel disruptors/innovators

Subcutaneous Drug Delivery Devices Market Growth & Trends:

The global subcutaneous drug delivery devices market size is expected to reach USD 51.8 billion by 2030, registering to grow at a CAGR of 7.6% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis.

In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.

Subcutaneous Drug Delivery Devices Market Report Highlights:

• North America accounted for the largest revenue share in 2024 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income
• By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability
• By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices
• Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Distribution Channel
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Distribution Channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of chronic diseases
    • 3.2.1.2. Increasing production of biologics
    • 3.2.1.3. Increasing product innovations and approvals
    • 3.2.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced delivery systems
    • 3.2.2.2. Lack of awareness in developing countries
• 3.3. Subcutaneous Drug Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Subcutaneous Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Subcutaneous Drug Delivery Devices Market: Product Movement Analysis
• 4.3. Subcutaneous Drug Delivery Devices Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Prefilled Syringes
  • 4.5.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Pen Injectors
  • 4.6.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Auto Injectors
  • 4.7.1. Auto Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Wearable Injectors
  • 4.8.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Needle-free Injectors
  • 4.9.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subcutaneous Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Subcutaneous Drug Delivery Devices Market: Distribution Channel Movement Analysis
• 5.3. Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospital Pharmacies
  • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Retail Pharmacies
  • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Online Pharmacies
  • 5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Subcutaneous Drug Delivery Devices Market Movement Analysis
• 6.3. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Japan Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. China Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. India Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. South Korea Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Australia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Thailand Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Brazil Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Argentina Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. South Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. UAE Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Kuwait Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Gerresheimer AG
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Medtronic Plc
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Ypsomed AG
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Elcam Medical Group
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Novo Nordisk
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Insulet Corporation
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Becton, Dickinson and Company
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. West Pharmaceutical Services, Inc.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. PharmaJet
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Unilife Corporation
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Inolife Sciences
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives